CACNA1C Variants Found in Focal Epilepsy Patients
New research identifies three genetic variants that may contribute to seizure activity in some individuals.
Updated on Oct. 23, 2026 in Alzheimer’s
Researchers have identified three specific de novo CACNA1C variants in patients with focal epilepsy, expanding the known clinical role of these genetic markers. This discovery provides new insight for individuals currently undergoing genetic testing for unexplained neurological conditions.
Why it matters
Understanding the genetic drivers of epilepsy is critical for personalizing treatment plans and managing associated risks. This research helps clarify the spectrum of symptoms linked to CACNA1C mutations, which were previously associated primarily with arrhythmias and developmental disorders.
Using trio-based whole-exome sequencing, researchers identified three de novo CACNA1C variants in patients with focal epilepsy that were classified as pathogenic or likely pathogenic according to ACMG standards. These findings add to a known catalog of 138 arrhythmia-linked and 30 developmental disorder-linked variants.
The players
American College of Medical Genetics and Genomics
A professional organization that establishes evidence-based standards and guidelines for clinical genetic testing and variant classification.
The details
The CACNA1C gene encodes a protein that forms the alpha-1 subunit of L-type voltage-gated calcium channels, which are vital for electrical signaling in the brain and heart. Mutations in this gene can disrupt normal calcium ion flow, leading to cellular dysfunction that may manifest as seizures, rhythm disturbances, or neurodevelopmental challenges. The severity of the clinical presentation in these patients ranged from seizure-free status to refractory epilepsy combined with developmental delays and arrhythmia.
Health Landscape
This research expands the clinical understanding of the CACNA1C gene, moving it beyond its established role in cardiac and developmental conditions. It reflects a growing trend in precision neurology to identify the rare genetic foundations of focal epilepsy.
If you or a family member are undergoing genetic evaluation for focal epilepsy, this finding emphasizes the importance of discussing specific genetic panels with a neurologist or genetic counselor. It is worth asking whether variants in calcium channel genes have been considered during your diagnostic process.
The takeaway
This discovery highlights that CACNA1C variants may contribute to a broader range of neurological symptoms than previously documented. Patients should work with their clinical team to determine if comprehensive genetic sequencing is appropriate for their specific health history.
Further reading
For more information on the intersection of genetics and neurological function, visit Alzheimer’s.
Source note: This article includes information reported by Journal of Medical Genetics.
